Famon Awal Bros Sedaya Expands Healthcare Portfolio Through Strategic Acquisition

Debt Conversion Transaction Details

PT Famon Awal Bros Sedaya Tbk (PRAY), listed on the Indonesia Stock Exchange, has successfully executed a debt-to-equity conversion transaction on 10 December 2025. The company acquired a 20.06% stake in PT Jala Mas Putra Rejeki as part of the debt conversion agreement initially signed on 16 September 2025. This strategic move was disclosed through an information disclosure to the Indonesia Stock Exchange.

Corporate Control and Shareholding Structure

The transaction resulted in Famon Awal Bros Sedaya becoming the controlling shareholder of Jala Mas Putra Rejeki following a comprehensive shareholders' agreement signed by all existing shareholders of the company. This development strengthens Famon Awal's position in the healthcare sector by expanding its portfolio and control over additional healthcare facilities.

Business Implications and Future Prospects

The acquisition represents a significant strategic move for Famon Awal Bros Sedaya as it expands its presence in Indonesia's healthcare industry. By gaining control of Jala Mas Putra Rejeki, the company not only increases its asset base but also enhances its market position in the competitive healthcare services market. This development is expected to contribute positively to the company's growth trajectory and financial performance in the coming periods.